Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
mi
from 43215
Bronx, NY
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Jeffrey Schultz, M.D.
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
494
mi
from 43215
Lynbrook, NY
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Ophthalmic Consultants of Long Island
494
mi
from 43215
Lynbrook, NY
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
355
mi
from 43215
Rochester, NY
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Rochester Ophthalmological Group
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
354
mi
from 43215
Charlotte, NC
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Charlotte Eye, Ear, Nose & Throat Associates
354
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
750
mi
from 43215
Tulsa, OK
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
The Eye Institute
750
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
1062
mi
from 43215
Austin, TX
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Texan Eye
1062
mi
from 43215
Austin, TX
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
1138
mi
from 43215
San Antonio, TX
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Medical Center Ophth. Associates
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
mi
from 43215
Salt Lake City, UT
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Stacy R. Smith, M.D.
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
426
mi
from 43215
Norfolk, VA
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Virginia Eye Consultants
426
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
493
mi
from 43215
Birmingham, AL
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
622
mi
from 43215
Little Rock, AR
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Arkansas Children's Hospital
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
432
mi
from 43215
Atlanta, GA
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Emory University/Childrens Healthcare of Atlanta
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
164
mi
from 43215
Ann Arbor, MI
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
618
mi
from 43215
Kansas City, MO
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
486
mi
from 43215
Bronx, NY
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Albert Einstein University Hospital
486
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
479
mi
from 43215
New York, NY
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
New York University Langone Medical Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
97
mi
from 43215
Cincinnati, OH
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Efficacy of Changing to Travatan From Prior Therapy
Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
Status: Enrolling
Updated:  4/22/2013
941
mi
from 43215
Fort Worth, TX
Efficacy of Changing to Travatan From Prior Therapy
Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
Status: Enrolling
Updated: 4/22/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
1661
mi
from 43215
Phoenix, AZ
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Saint Joseph's Hospital
1661
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
1950
mi
from 43215
La Jolla, CA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
UCSD Medical Center
1950
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
1982
mi
from 43215
Torrance, CA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
UCLA Medical Center
1982
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
1154
mi
from 43215
Aurora, CO
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Colorado Denver
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
188
mi
from 43215
Louisville, KY
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Kentuckiana Pulmonary Associates
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
343
mi
from 43215
Baltimore, MD
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Maryland Medical Center
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
642
mi
from 43215
Boston, MA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
642
mi
from 43215
Boston, MA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Boston University School of Medicine
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
643
mi
from 43215
Boston, MA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
397
mi
from 43215
Saint Louis, MO
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
352
mi
from 43215
Durham, NC
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
98
mi
from 43215
Cincinnati, OH
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
1
mi
from 43215
Columbus, OH
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
The Ohio State University, Wexner Medical Center
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
165
mi
from 43215
Pittsburgh, PA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
910
mi
from 43215
Dallas, TX
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Texas Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
991
mi
from 43215
Houston, TX
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
318
mi
from 43215
Falls Church, VA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Inova Fairfax Hospital
318
mi
from 43215
Falls Church, VA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
329
mi
from 43215
Milwaukee, WI
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Aurora St. Luke's Medical Center
329
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
1661
mi
from 43215
Phoenix, AZ
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Saint Joseph's Hospital
1661
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
1950
mi
from 43215
La Jolla, CA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
UCSD Medical Center
1950
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
1982
mi
from 43215
Torrance, CA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
UCLA Medical Center
1982
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
1154
mi
from 43215
Aurora, CO
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Colorado Denver
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
188
mi
from 43215
Louisville, KY
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Kentuckiana Pulmonary Associates
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
343
mi
from 43215
Baltimore, MD
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Maryland Medical Center
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
642
mi
from 43215
Boston, MA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
642
mi
from 43215
Boston, MA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Boston University School of Medicine
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
643
mi
from 43215
Boston, MA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
397
mi
from 43215
Saint Louis, MO
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
352
mi
from 43215
Durham, NC
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
98
mi
from 43215
Cincinnati, OH
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
1
mi
from 43215
Columbus, OH
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
The Ohio State University, Wexner Medical Center
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
165
mi
from 43215
Pittsburgh, PA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials